Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1MAU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,027
Award facts
- Contract value 100% obligated
- $15,027.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,027.20 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was awarded on January 12, 2026 without a set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Ozempic order supports the Department of Defense's medical supply chain requirements, particularly for military and veteran healthcare systems. As a non-set-aside competitive award, this contract demonstrates AmerisourceBergen's established capability to meet federal procurement standards and its ongoing role as a key supplier for essential pharmaceutical products to the military medical establishment.
Quick answers
Who was awarded contract SPE2DR26F1MAU?
SPE2DR26F1MAU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1MAU worth?
The government has obligated $15,027 on SPE2DR26F1MAU.
Is contract SPE2DR26F1MAU an order under another contract?
Yes. SPE2DR26F1MAU is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1MAU competed?
The extent of competition for SPE2DR26F1MAU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award